In a world where health is our greatest wealth, the advancement of genetic testing represents a beacon of hope for millions affected by rare diseases. Often, these conditions go undiagnosed for years, leaving patients and families in a constant search for answers. Genetic testing not only offers a pathway to accurate diagnosis but also opens the door to personalized treatments, significantly improving patients' quality of life. By identifying specific mutations causing diseases, doctors can tailor interventions to individual needs, something unthinkable just a decade ago. Raising awareness about the importance of genomics in modern medicine is crucial. Investing in research and development, as well as in the accessibility of these tests, is essential to move toward a future where every rare disease can be effectively detected and treated. Let's make genetic testing a priority in our healthcare system. Because when it comes to rare diseases, genetic knowledge is not just power; it's hope. Igenomix Latam truly committed to scientific community and healthcare sector in the pathway pf genetic testing democratization. https://lnkd.in/eZfUP4eM #cgt #genes #panels #gpdx
Today is Rare Disease Day. 🧬 There are 300 million people worldwide living with a rare disease. 🧬 There are over 6,000 identified rare diseases. 🧬 72% of all rare diseases are genetic. 🧬 70% of genetic rare diseases start in childhood. 🧬 5% of the worldwide population are currently affected by rare diseases. Researchers play a critical role in advancing diagnosis and treatment for people with rare diseases. Their work leads to improved understanding, earlier detection, and the development of effective therapies. #Rarediseaseday2024 #Igenomix #VitrolifeGroup #Genetics #Research
